品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
麦克林 | X860865-5mg | 5mg | 现货 | 945755-56-6 |
XL019 XL019 干冰运输(加收0元干冰费用) |
>95% |
|
|
麦克林 | X860865-25mg | 25mg | 现货 | 945755-56-6 |
XL019 XL019 干冰运输(加收0元干冰费用) |
>95% |
|
|
麦克林 | X860865-100mg | 100mg | 现货 | 945755-56-6 |
XL019 XL019 干冰运输(加收0元干冰费用) |
>95% |
|
|
麦克林 | X797190-1ml | 1ml | 10个工作日 | 945755-56-6 |
XL019 XL019 干冰运输(加收0元干冰费用) |
10mM in DMSO |
|
|
阿拉丁 | X127151-5mg | 5mg | 现货 | 945755-56-6 |
XL019,JAK2抑制剂 XL019 |
Moligand™, ≥98% |
|
|
阿拉丁 | X127151-25mg | 25mg | 现货 | 945755-56-6 |
XL019,JAK2抑制剂 XL019 |
Moligand™, ≥98% |
|
|
阿拉丁 | X127151-100mg | 100mg | 现货 | 945755-56-6 |
XL019,JAK2抑制剂 XL019 |
Moligand™, ≥98% |
|
|
阿拉丁 | X127151-10mg | 10mg | 现货 | 945755-56-6 |
XL019,JAK2抑制剂 XL019 |
Moligand™, ≥98% |
|
|
阿拉丁 | X127151-50mg | 50mg | 现货 | 945755-56-6 |
XL019,JAK2抑制剂 XL019 |
Moligand™, ≥98% |
|
|
阿拉丁 | X427046-1ml | 1ml | 现货 | 945755-56-6 |
XL019 XL019 |
Moligand™, 10mM in DMSO |
|
|
罗恩 | R021605-25mg | 25mg | 5~7个工作日 | 945755-56-6 |
(2S)-N-[4-[2-[[4-(4-吗啉基)苯基]氨... (S)-N-(4-(2-((4-morpholinoph... |
99% |
|
|
罗恩 | R021605-5mg | 5mg | 5~7个工作日 | 945755-56-6 |
(2S)-N-[4-[2-[[4-(4-吗啉基)苯基]氨... (S)-N-(4-(2-((4-morpholinoph... |
99% |
|
|
毕得 | BD256287-5mg | 5mg | 现货 | 945755-56-6 |
(S)-N-(4-(2-((4-吗啉代苯基)氨基)嘧啶-... (S)-N-(4-(2-((4-Morpholinoph... |
98% |
|
|
毕得 | BD256287-25mg | 25mg | 现货 | 945755-56-6 |
(S)-N-(4-(2-((4-吗啉代苯基)氨基)嘧啶-... (S)-N-(4-(2-((4-Morpholinoph... |
98% |
|
|
毕得 | BD256287-50mg | 50mg | 现货 | 945755-56-6 |
(S)-N-(4-(2-((4-吗啉代苯基)氨基)嘧啶-... (S)-N-(4-(2-((4-Morpholinoph... |
98% |
|
|
毕得 | BD256287-100mg | 100mg | 现货 | 945755-56-6 |
(S)-N-(4-(2-((4-吗啉代苯基)氨基)嘧啶-... (S)-N-(4-(2-((4-Morpholinoph... |
98% |
|
|
源叶 | S81154-5mg | 5mg | 现货 | 945755-56-6 |
XL019 XL019 |
98% |
|
|
源叶 | S81154-10mg | 10mg | 现货 | 945755-56-6 |
XL019 XL019 |
98% |
|
|
源叶 | S81154-25mg | 25mg | 现货 | 945755-56-6 |
XL019 XL019 |
98% |
|
|
源叶 | S81154-100mg | 100mg | 期货,请咨询 | 945755-56-6 |
XL019 XL019 |
98% |
|
|